1. Home
  2. SGMO vs TSE Comparison

SGMO vs TSE Comparison

Compare SGMO & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • TSE
  • Stock Information
  • Founded
  • SGMO 1995
  • TSE 2010
  • Country
  • SGMO United States
  • TSE United States
  • Employees
  • SGMO N/A
  • TSE N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • TSE Major Chemicals
  • Sector
  • SGMO Health Care
  • TSE Industrials
  • Exchange
  • SGMO Nasdaq
  • TSE Nasdaq
  • Market Cap
  • SGMO 122.8M
  • TSE 112.7M
  • IPO Year
  • SGMO 2000
  • TSE 2014
  • Fundamental
  • Price
  • SGMO $0.48
  • TSE $2.85
  • Analyst Decision
  • SGMO Buy
  • TSE
  • Analyst Count
  • SGMO 6
  • TSE 0
  • Target Price
  • SGMO $4.50
  • TSE N/A
  • AVG Volume (30 Days)
  • SGMO 5.1M
  • TSE 557.4K
  • Earning Date
  • SGMO 08-05-2025
  • TSE 08-06-2025
  • Dividend Yield
  • SGMO N/A
  • TSE 1.39%
  • EPS Growth
  • SGMO N/A
  • TSE N/A
  • EPS
  • SGMO N/A
  • TSE N/A
  • Revenue
  • SGMO $63,756,000.00
  • TSE $3,394,000,000.00
  • Revenue This Year
  • SGMO $1.29
  • TSE $1.84
  • Revenue Next Year
  • SGMO $1.60
  • TSE $4.44
  • P/E Ratio
  • SGMO N/A
  • TSE N/A
  • Revenue Growth
  • SGMO 239.92
  • TSE N/A
  • 52 Week Low
  • SGMO $0.37
  • TSE $2.16
  • 52 Week High
  • SGMO $3.18
  • TSE $7.05
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 45.61
  • TSE 39.95
  • Support Level
  • SGMO $0.48
  • TSE $2.85
  • Resistance Level
  • SGMO $0.54
  • TSE $3.14
  • Average True Range (ATR)
  • SGMO 0.04
  • TSE 0.21
  • MACD
  • SGMO -0.00
  • TSE -0.04
  • Stochastic Oscillator
  • SGMO 13.62
  • TSE 1.38

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: